RS53211B - DERIVATI PIRIDO[2,3-d]PIRIMIDINA, NJIHOVO DOBIJANJE, NJIHOVA PRIMENA U TERAPIJI - Google Patents

DERIVATI PIRIDO[2,3-d]PIRIMIDINA, NJIHOVO DOBIJANJE, NJIHOVA PRIMENA U TERAPIJI

Info

Publication number
RS53211B
RS53211B RS20140121A RSP20140121A RS53211B RS 53211 B RS53211 B RS 53211B RS 20140121 A RS20140121 A RS 20140121A RS P20140121 A RSP20140121 A RS P20140121A RS 53211 B RS53211 B RS 53211B
Authority
RS
Serbia
Prior art keywords
compound
formula
group
solvent
amine
Prior art date
Application number
RS20140121A
Other languages
English (en)
Serbian (sr)
Inventor
Bernard Bourrie
Pierre Casellas
Samir Jegham
Claude Muneaux
Pierre Perreaut
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi filed Critical Sanofi
Publication of RS53211B publication Critical patent/RS53211B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RS20140121A 2005-07-01 2006-06-29 DERIVATI PIRIDO[2,3-d]PIRIMIDINA, NJIHOVO DOBIJANJE, NJIHOVA PRIMENA U TERAPIJI RS53211B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0507032A FR2887882B1 (fr) 2005-07-01 2005-07-01 Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique

Publications (1)

Publication Number Publication Date
RS53211B true RS53211B (sr) 2014-08-29

Family

ID=36096420

Family Applications (2)

Application Number Title Priority Date Filing Date
RS20140121A RS53211B (sr) 2005-07-01 2006-06-29 DERIVATI PIRIDO[2,3-d]PIRIMIDINA, NJIHOVO DOBIJANJE, NJIHOVA PRIMENA U TERAPIJI
RSP-2009/0225A RS50781B (sr) 2005-07-01 2006-06-29 Derivati pirido (2,3-d) pirimidina, njihovo dobijanje, njihova primena u terapiji

Family Applications After (1)

Application Number Title Priority Date Filing Date
RSP-2009/0225A RS50781B (sr) 2005-07-01 2006-06-29 Derivati pirido (2,3-d) pirimidina, njihovo dobijanje, njihova primena u terapiji

Country Status (40)

Country Link
US (2) US7504406B2 (enExample)
EP (2) EP2020410B1 (enExample)
JP (1) JP4472009B2 (enExample)
KR (1) KR101298344B1 (enExample)
CN (2) CN101213196B (enExample)
AR (1) AR054812A1 (enExample)
AT (1) ATE423119T1 (enExample)
AU (1) AU2006264801B2 (enExample)
BR (1) BRPI0613020A2 (enExample)
CA (1) CA2610794C (enExample)
CR (1) CR9568A (enExample)
CY (2) CY1110457T1 (enExample)
DE (1) DE602006005246D1 (enExample)
DK (2) DK2020410T3 (enExample)
DO (1) DOP2006000145A (enExample)
EA (1) EA014312B1 (enExample)
EC (1) ECSP078011A (enExample)
ES (2) ES2322101T3 (enExample)
FR (1) FR2887882B1 (enExample)
HR (2) HRP20090236T1 (enExample)
IL (1) IL187900A0 (enExample)
JO (1) JO2550B1 (enExample)
MA (1) MA29561B1 (enExample)
ME (1) ME01813B (enExample)
MX (1) MX2007016239A (enExample)
MY (1) MY143089A (enExample)
NO (1) NO20080418L (enExample)
NZ (1) NZ564072A (enExample)
PA (1) PA8684801A1 (enExample)
PE (1) PE20070139A1 (enExample)
PL (2) PL2020410T3 (enExample)
PT (2) PT1902054E (enExample)
RS (2) RS53211B (enExample)
SI (2) SI2020410T1 (enExample)
TN (1) TNSN07440A1 (enExample)
TW (1) TWI321566B (enExample)
UA (1) UA92021C2 (enExample)
UY (1) UY29645A1 (enExample)
WO (1) WO2007003765A1 (enExample)
ZA (1) ZA200711032B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2873118B1 (fr) 2004-07-15 2007-11-23 Sanofi Synthelabo Derives de pyrido-pyrimidine, leur application en therapeutique
FR2887882B1 (fr) * 2005-07-01 2007-09-07 Sanofi Aventis Sa Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
FR2896246B1 (fr) 2006-01-13 2008-08-15 Sanofi Aventis Sa Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique.
FR2910813B1 (fr) * 2006-12-28 2009-02-06 Sanofi Aventis Sa Nouvelle utilisation therapeutique pour le traitement des leucemies
CN102186845B (zh) 2008-10-17 2016-09-07 阿卡制药有限公司 S1p受体调节剂以及它们的用途
EP2344446A4 (en) 2008-10-17 2012-04-04 Akaal Pharma Pty Ltd S1P RECEPTOR MODULATORS
FR2948568B1 (fr) 2009-07-30 2012-08-24 Sanofi Aventis Formulation pharmaceutique
CN103204827B (zh) * 2012-01-17 2014-12-03 上海科州药物研发有限公司 作为蛋白激酶抑制剂的苯并噻二唑化合物及其制备方法和用途
EP2638911A1 (en) 2012-03-14 2013-09-18 Sanofi Novel combinations for treating acute myeloid leukaemia or chronic myeloid leukaemia
CN103833771A (zh) * 2012-11-22 2014-06-04 天津滨江药物研发有限公司 作为蛋白激酶Mek抑制剂的苯并五元杂环化合物及其制备方法和用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1171218A (en) 1967-11-09 1969-11-19 Parke Davis & Co New Heterocyclic Amine Compounds and Methods for their Production
JPH04128276A (ja) 1990-09-19 1992-04-28 Pfizer Pharmaceut Co Ltd アミノベンゾサルタム誘導体およびその用途
WO1996015128A2 (en) * 1994-11-14 1996-05-23 Warner-Lambert Company 6-ARYL PYRIDO[2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION
IL115256A0 (en) 1994-11-14 1995-12-31 Warner Lambert Co 6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
US5620981A (en) 1995-05-03 1997-04-15 Warner-Lambert Company Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation
IL117923A (en) 1995-05-03 2000-06-01 Warner Lambert Co Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
BR0107751A (pt) * 2000-01-25 2002-11-12 Warner Lambert Co Inibidores de pirido[2,3-d]pirimidina-2,7-diaminas quinase
NZ520962A (en) * 2000-03-06 2003-09-26 Warner Lambert Co 5-alkylpyrido[2,3-d]pyrimidines cyclin-dependent tyrosine kinase inhibitors
WO2002012238A2 (en) 2000-08-04 2002-02-14 Warner-Lambert Company 2-(4-PYRIDYL)AMINO-6-DIALKOXYPHENYL-PYRIDO[2,3-d]PYRIMIDIN-7-ONES
WO2003000011A2 (en) * 2001-06-21 2003-01-03 Ariad Pharmaceuticals, Inc. Novel pyridopyrimidines and uses thereof
AU2002952453A0 (en) * 2002-11-01 2002-11-21 Novogen Research Pty Ltd Aminated isoflavonoid derivatives and uses thereof
WO2004063195A1 (en) 2003-01-03 2004-07-29 Sloan-Kettering Institute For Cancer Research Pyridopyrimidine kinase inhibitors
TW200502236A (en) * 2003-03-28 2005-01-16 Hoffmann La Roche Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
WO2005105097A2 (en) 2004-04-28 2005-11-10 Gpc Biotech Ag Pyridopyrimidines for treating inflammatory and other diseases
FR2873118B1 (fr) 2004-07-15 2007-11-23 Sanofi Synthelabo Derives de pyrido-pyrimidine, leur application en therapeutique
FR2887882B1 (fr) * 2005-07-01 2007-09-07 Sanofi Aventis Sa Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
FR2896246B1 (fr) 2006-01-13 2008-08-15 Sanofi Aventis Sa Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique.
US8338435B2 (en) * 2006-07-20 2012-12-25 Gilead Sciences, Inc. Substituted pyrido(3,2-D) pyrimidines and pharmaceutical compositions for treating viral infections

Also Published As

Publication number Publication date
AR054812A1 (es) 2007-07-18
UY29645A1 (es) 2007-01-31
PL2020410T3 (pl) 2014-05-30
KR101298344B1 (ko) 2013-08-20
CY1114989T1 (el) 2016-12-14
CA2610794C (fr) 2012-02-21
ME01813B (me) 2014-09-20
DOP2006000145A (es) 2008-01-31
TNSN07440A1 (en) 2009-03-17
US20080176874A1 (en) 2008-07-24
EP1902054A1 (fr) 2008-03-26
DK1902054T3 (da) 2009-06-15
NO20080418L (no) 2008-03-28
ZA200711032B (en) 2009-04-29
SI2020410T1 (sl) 2014-04-30
MX2007016239A (es) 2008-03-06
PA8684801A1 (es) 2007-01-17
FR2887882A1 (fr) 2007-01-05
TW200745102A (en) 2007-12-16
EA200800223A1 (ru) 2008-06-30
CY1110457T1 (el) 2015-04-29
JP4472009B2 (ja) 2010-06-02
PT2020410E (pt) 2014-03-20
MY143089A (en) 2011-03-15
ES2450067T3 (es) 2014-03-21
WO2007003765A1 (fr) 2007-01-11
DK2020410T3 (en) 2014-03-24
DE602006005246D1 (de) 2009-04-02
EP2020410A1 (fr) 2009-02-04
RS50781B (sr) 2010-08-31
PE20070139A1 (es) 2007-03-07
KR20080021714A (ko) 2008-03-07
PL1902054T3 (pl) 2009-07-31
CN102260258A (zh) 2011-11-30
EA014312B1 (ru) 2010-10-29
UA92021C2 (ru) 2010-09-27
NZ564072A (en) 2012-02-24
BRPI0613020A2 (pt) 2010-12-14
AU2006264801B2 (en) 2012-05-10
TWI321566B (en) 2010-03-11
HRP20090236T1 (hr) 2009-05-31
CN101213196B (zh) 2011-09-07
CA2610794A1 (fr) 2007-01-11
CN101213196A (zh) 2008-07-02
IL187900A0 (en) 2008-03-20
ECSP078011A (es) 2008-01-23
JP2008544975A (ja) 2008-12-11
HK1122797A1 (en) 2009-05-29
MA29561B1 (fr) 2008-06-02
ES2322101T3 (es) 2009-06-16
CN102260258B (zh) 2015-01-07
EP2020410B1 (fr) 2013-12-18
CR9568A (es) 2008-02-20
ATE423119T1 (de) 2009-03-15
SI1902054T1 (sl) 2009-06-30
JO2550B1 (en) 2010-09-05
PT1902054E (pt) 2009-04-22
HRP20140246T1 (hr) 2014-06-20
US20090163522A1 (en) 2009-06-25
US7504406B2 (en) 2009-03-17
FR2887882B1 (fr) 2007-09-07
US8008310B2 (en) 2011-08-30
EP1902054B1 (fr) 2009-02-18
AU2006264801A1 (en) 2007-01-11

Similar Documents

Publication Publication Date Title
EP3204381B1 (en) N-pyridinyl acetamide derivatives as wnt signalling pathway inhibitors
CN102666536B (zh) 萘啶衍生物及其作为激酶抑制剂的用途
US7504406B2 (en) Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the same
WO2022081912A2 (en) Heterocycles and uses thereof
US20070167469A1 (en) Pyrido-pyrimidine derivatives, preparation thereof, and therapeutic use thereof
RS20050864A (sr) Novi piridopirazini i njihova upotreba kao inhibitora kinaza
JP2009523159A (ja) ピリドピリミドン誘導体、これらの調製、これらの治療上の使用
EP4293029B1 (en) Azaheteroaryl compound, preparation method therefor, and application thereof
CN110283174A (zh) 一类PI3Kδ抑制剂及其用途
WO2022271562A1 (en) Heterocycles and uses thereof
RS61833B1 (sr) Derivati piridohinazolina korisni kao inhibitori proteinske kinaze
HK40104987A (en) Azaheteroaryl compound, preparation method therefor, and application thereof
HK1163102A (en) Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the same
HK1122797B (en) Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the same